Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis
Autor: | Nicolas Boissel, Florence Rabian, Raphael Itzykson, Hervé Dombret, Marie Sebert, Valerie Seegers, Elie Azoulay, Lionel Adès, Marco Cerrano, Etienne Lengliné, Emmanuel Raffoux, Virginie Lemiale |
---|---|
Rok vydání: | 2019 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty Leukocytosis business.industry Tumor burden Myeloid leukemia Hematology Leukemia Myeloid Acute 03 medical and health sciences 0302 clinical medicine Prednisone 030220 oncology & carcinogenesis Internal medicine medicine Humans Hydroxyurea Relapse risk business 030215 immunology medicine.drug |
Zdroj: | Leukemia & Lymphoma. 61:737-740 |
ISSN: | 1029-2403 1042-8194 |
DOI: | 10.1080/10428194.2019.1683735 |
Popis: | Since the demonstration that poor prednisone response was associated with an increased relapse risk, early evaluation of in vivo tumor burden reduction has been established as the most powerful pro... |
Databáze: | OpenAIRE |
Externí odkaz: |